Octagon has released a new process management platform that provides foundation for data, document, and submission management.
OCTAGON RESEARCH SOLUTIONS, INC. LAUNCHES VIEWPOINT® QUANTUM PLATFORMProcess management platform provides foundation for data, document and submission management.
(WAYNE, PA, November 6, 2008) - CEO & Chairman Jim Walker of Octagon Research Solutions, Inc., a pioneer and leading provider of breakthrough software and services to the life sciences industry, today announced the release of the ViewPoint®Quantum platform. The platform supports optional business modules and is the foundation for the ViewPoint Quantum environment, which provides management and control of complex processes across the R&D enterprise. ViewPoint Quantum is the industry’s first comprehensive solution to connect content, people, processes and technologies by aligning and automating work efforts for challenging processes such as maintenance and management of standards implementations and content and submission management.
The ViewPoint Quantum platform provides Business Process Management capabilities including workflow, issue management, search, metadata and document storage, as well as integrated connectivity with other content repositories. It also ensures that common functionality will be available across critical business modules including dynamic reporting capabilities, issue management capabilities and powerful workflows that are the basis for cross-functional efficiency.
The launch of the platform will be followed by subsequent releases of business modules that provide functionality to support submission standards such as eCTD (electronic Common Technical Document) and CDISC (Clinical Data Interchange Standards Consortium) and complex activities relating to these standards such as global submission publishing, compilation and lifecycle management. Monique Garrett, vice president, Marketing, Octagon Research Solutions, Inc., noted, “The ViewPoint Quantum platform represents the first milestone in our rolling launch strategy. ViewPoint Quantum combines the ease and usability of desktop tools with the power of a platform approach. We believe that the market has outgrown disaggregated and disposable desktop tools and is looking for a long-term, approach to managing complex processes.”
Kirk Gallion, president, Octagon Research Solutions, Inc., added, “This is an educated marketplace and one that is seeking real-time solutions from a technology and a resourcing perspective. The ViewPoint Quantum platform enables us to deliver our expert services through our Integrated Sourcing model, which provides the technology and resources that clients need to complete their submission capabilities. The power of utilizing one environment to manage resources, emerging content (data and documents), final submission deliverables and any issues associated with the process is compelling and seems to be resonating throughout industry.”
Octagon will be demonstrating ViewPoint Quantum at their exhibit booth (#5) at the DIA 7th Annual Electronic Submissions Conference: “eCTD, The Adventure Continues”, in San Diego, CA on November 6-7, 2008.
For more information about ViewPoint Quantum or to learn more about Octagon’s people, process and technology, please visit www.viewpointquantum.com. To schedule a demonstration, please contact Octagon Research Solutions, Inc. at 610.535.6500.
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading provider of breakthrough software and services to the life sciences industry. Octagon’s eCTD and CDISC solutions provide the people, process and technology required to optimize drug development from data collection to submission. Our regulatory, clinical, process and software offerings provide a unique combination of deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Berkhamsted, UK. Octagon’s EDC Operations are located in Mountain View, CA. For more information please visit www.octagonresearch.com.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
A Guide to Patient Engagement & Recruitment Solutions
March 18th 2025Clinical trials have become increasingly complex over the past decades, making participant recruitment more challenging than ever. This guide explores common recruitment obstacles and offers strategies to overcome them using a patient engagement and recruitment solution.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Bridging the Gap: How Chiesi Used External Collaboration to Get Closer to Patients
March 18th 2025Chiesi partnered with Citeline to enhance clinical trial awareness and patient engagement through its FREUD initiative by launching a Trial Portfolio Website, activating 150+ sites, and generating 600+ qualified referrals—learn more about how Citeline helped improve study discoverability, streamline recruitment, and strengthen Chiesi’s presence in key therapeutic areas.
Citeline Patient Engagement & Recruitment Solutions
March 18th 2025Watch Citeline’s 15-minute presentation from Clinical Leader’s Patient Engagement & Recruitment Solutions Expo, where VP Matt Holms explores Direct-to-Data (DTD) patient recruitment. This session takes a deep dive into how complex algorithms, tokenized data, and large data assets can optimize enrollment, highlighting the importance of early strategic recruitment planning and breaking down the unique benefits and real-world applications of DTD.